HIT — Health In Tech Income Statement
0.000.00%
- $87.85m
- $80.18m
- $33.33m
Annual income statement for Health In Tech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 5.77 | 19.2 | 19.5 | 33.3 |
| Cost of Revenue | ||||
| Gross Profit | 5.44 | 16.8 | 15.4 | 20.9 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 5.56 | 15.8 | 18.5 | 31.8 |
| Operating Profit | 0.206 | 3.38 | 0.99 | 1.53 |
| Total Net Non Operating Interest Income / Expense | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 0.201 | 3.42 | 0.889 | 1.67 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 0.08 | 2.48 | 0.67 | 1.28 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | 0.08 | 2.48 | 0.67 | 1.28 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 0.08 | 2.48 | 0.67 | 1.28 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.007 | 0.018 | 0.012 | 0.022 |